Skip to main content
Clinical Trials/KCT0003515
KCT0003515
Completed
未知

To evaluate the clinical and radiological results of biodegradable calcium phosphate bone cement for the augmentation of internally-fixed unstable trochanteric fracture using intramedullary nail

Kangdong Sacred Heart Hospital0 sites20 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculo-skeletal system and connective tissue
Sponsor
Kangdong Sacred Heart Hospital
Enrollment
20
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • The trial included patients with unstable trochanteric (three or four parts fractures, AO type A2, Evans unstable Type 1\). Additional inclusion criteria were as follows: age more than 65 years, walking with or without support, less than 72 hours between the fracture and surgery, and signed informed consent.

Exclusion Criteria

  • 1\) stable two parts factures (AO type A1, Evans stable Type 1\);
  • 2\) transtrochanteric fractures with a transverse of reversed/oblique fracture line at the level of the lesser trochanter (AO type A3, Evans Type 2\)
  • 3\) pathological fractures related to tumors and subtrochanteric fractures;
  • 4\) tip\-apex distance (TAD) \> 18 mm
  • 5\) limited ability to perform objective functional tests (dementia, serious concomitant illness or mental instability, or neurosensory, neuromuscular or musculoskeletal deficiency
  • 6\) soft\-tissue infection at the operation site
  • 7\) concurrent fractures that would affect the post\-operative functional outcome.

Outcomes

Primary Outcomes

Not specified

Similar Trials